GDC-0152

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGDC-0152
Drug Alias NameRG-7419GDC-0152
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs
Mechanisms of ActioncIAP1/cIAP2 inhibitorsDiablo homolog, mitochondrial stimulants
TargetscIAP1/cIAP2Diablo homolog, mitochondrial
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A